Drug intelligence / Profile preview

Biombalance

Development stage
Preclinical
Lead developer
Groupe Berkem
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Biombalance is a proprietary, oligomeric procyanidin-rich grape seed extract (GSE) developed by Euromed as a multifunctional nutraceutical ingredient for gut health and gut-brain axis modulation. It exhibits potent antioxidant, anti-inflammatory, and antibacterial properties. Mechanistically, Biombalance protects intestinal epithelial cells from oxidative damage, inhibits the expression of proinflammatory markers such as IL-6, IL-17, and TNF-α, and selectively modulates the gut microbiota by increasing beneficial taxa like *Bifidobacterium* and *Lactobacillus* while reducing potentially harmful Proteobacteria. Furthermore, it has been shown to influence key gut-brain axis mediators, including GLP-1 and its receptor. Preclinical studies in mice models of colitis have demonstrated its potential to reduce gut inflammation and oxidative stress, partly through modifications of the microbiota and its metabolites.

Brand names
Biombalance
Other names
BBoligomeric procyanidin-rich grape seed extract
02

Targets

IL-6 (Interleukin 6)NPYR (Neuropeptide Y receptors)NOS2 (Nitric Oxide Synthase 2)GLP1R (GLP-1R)

Beyond the preview

Go deeper on Biombalance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biombalance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call